Medications for the treatment of obesity.

Carette, C; Rives-Lange, C; Czernichow, S

Carette, C; Rives-Lange, C; Czernichow, S.

Afiliación

Carette C; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France.
Rives-Lange C; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France.
Czernichow S; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France. Electronic address: sebastien.czernichow@aphp.fr.

J Visc Surg ; 160(2S): S12-S14, 2023 04.

Article en En | MEDLINE | ID: mdl-36725455

Asunto(s)

Leptina; Obesidad; Humanos; Leptina/metabolismo; Leptina/farmacología; Obesidad/tratamiento farmacológico; Hipotálamo/metabolismo

Palabras clave

GLP1 receptor agonists; Glucagon intestinal peptide (GIP); Hypothalamus; Leptin-melanocortin Leptin; Suspensive pharmacotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leptina / Obesidad Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Visc Surg Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google